Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum

NCT00730717 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Pyoderma Gangrenosum

Interventions

DRUG: Humira
DRUG: Humira

Sponsor

Wright State University

Collaborators

[object Object]
[object Object]